You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

TRIPROLIDINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Triprolidine Hydrochloride patents expire, and what generic alternatives are available?

Triprolidine Hydrochloride is a drug marketed by Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, Watson Labs, Ivax Sub Teva Pharms, Superpharm, and Wockhardt. and is included in eight NDAs.

The generic ingredient in TRIPROLIDINE HYDROCHLORIDE is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIPROLIDINE HYDROCHLORIDE?
  • What are the global sales for TRIPROLIDINE HYDROCHLORIDE?
  • What is Average Wholesale Price for TRIPROLIDINE HYDROCHLORIDE?
Summary for TRIPROLIDINE HYDROCHLORIDE
Drug patent expirations by year for TRIPROLIDINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for TRIPROLIDINE HYDROCHLORIDE

US Patents and Regulatory Information for TRIPROLIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 085940-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Superpharm TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088578-001 Feb 21, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Vitarine TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride TABLET;ORAL 085610-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt TRIPROLIDINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE AND CODEINE PHOSPHATE codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088833-001 Nov 16, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Halsey TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 088735-001 Jan 17, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharm Assoc TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 087514-001 Feb 10, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 085273-001 Dec 12, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.